Exact Mass: 449.27503900000005
Exact Mass Matches: 449.27503900000005
Found 500 metabolites which its exact mass value is equals to given mass value 449.27503900000005,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Deoxycholic acid glycine conjugate
C26H43NO5 (449.31410680000005)
Deoxycholic acid glycine conjugate, or or Deoxyglycocholic acid or Deoxygcholylglycine is a bile salt formed in the liver by conjugation of deoxycholate with glycine. It usually exists as the sodium salt. Deoxygcholylglycine is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID: 16949895). As a bile acid Deoxyglycocholic acid acts as a detergent to solubilize fats for absorption and is itself absorbed. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, and depends only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine, and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH, and consequently require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). Deoxyglycocholic acid is used as a cholagogue and choleretic. Deoxycholic acid glycine conjugate, or Deoxygcholylglycine, is an acyl glycine and a bile acid-glycine conjugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID:16949895). As a bile salt it acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as a cholagogue and choleretic. [HMDB] D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids D013501 - Surface-Active Agents > D003902 - Detergents Glycodeoxycholic Acid is an endogenous metabolite. Glycodeoxycholic Acid is an endogenous metabolite.
Glycine chenodeoxycholate
C26H43NO5 (449.31410680000005)
Chenodeoxycholic acid glycine conjugate is an acyl glycine and a bile acid-glycine conugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID: 16949895). This compound usually exists as the sodium salt and acts as a detergent to solubilize fats for absorption and is itself absorbed. It is a cholagogue and choleretic. Glycochenodeoxycholic acid (Chenodeoxycholylglycine) is a bile acid formed in the liver from chenodeoxycholate and glycine. It acts as a detergent to solubilize fats for absorption and is itself absorbed. Glycochenodeoxycholic acid (Chenodeoxycholylglycine) induces hepatocyte apoptosis[1][2].
Gentamicinc1A
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic
Chenodeoxyglycocholic acid
C26H43NO5 (449.31410680000005)
Chenodeoxyglycocholic acid is a glycine conjugated bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). Chenodeoxyglycocholic acid is a glycine conjugated bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135) [HMDB] COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Glycochenodeoxycholic acid (Chenodeoxycholylglycine) is a bile acid formed in the liver from chenodeoxycholate and glycine. It acts as a detergent to solubilize fats for absorption and is itself absorbed. Glycochenodeoxycholic acid (Chenodeoxycholylglycine) induces hepatocyte apoptosis[1][2].
N-(3α,12α-dihydroxy-5β-cholan-24-oyl)-glycine
C26H43NO5 (449.31410680000005)
Cadabicine methyl ether
C26H31N3O4 (449.23144460000003)
Cadabicine methyl ether is found in fruits. Cadabicine methyl ether is an alkaloid from the stem bark of the famine food Cadaba farinosa (luquata sigmama).
Glycoursodeoxycholic acid
C26H43NO5 (449.31410680000005)
Glycoursodeoxycholic acid is an acyl glycine and a bile acid-glycine conjugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID: 16949895). Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). Glycoursodeoxycholic acid is an acyl glycine and a bile acid-glycine conjugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID:16949895). Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids Glycoursodeoxycholic acid, a acyl glycine and a bile acid-glycine conjugate, is a metabolite of ursodeoxycholic acid.
N-Eicosapentaenoyl Phenylalanine
C29H39NO3 (449.29297840000004)
N-eicosapentaenoyl phenylalanine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Eicosapentaenoic acid amide of Phenylalanine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Eicosapentaenoyl Phenylalanine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Eicosapentaenoyl Phenylalanine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Chenodeoxycholylglycine
C26H43NO5 (449.31410680000005)
Deoxycholylglycine
C26H43NO5 (449.31410680000005)
4-[(S)-((2R,5S)-4-Allyl-2,5-dimethyl-piperazin-1-yl)-(3-methoxy-phenyl)-methyl]-N,N-diethyl-benzamide
6-(3-(Pyrrolidin-1-yl)propoxy)-2-(4-(3-(pyrrolidin-1-yl)propoxy)phenyl)benzo[d]oxazole
E6446 is a potent and orally acitve TLR7 and TLR9 antagonist, used in the research of deleterious inflammatory responses. E6446 is also a potent SCD1 inhibitor (KD: 4.61 μM), significantly inhibiting adipogenic differentiation and hepatic lipogenesis through SCD1-ATF3 signaling. E6446 also improves liver pathology in high-fat diet (HFD)-fed mice and may be useful in the study of non-alcoholic fatty liver disease (NAFLD)[1][2][3].
Gentamicin C
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins
Glycohyodeoxycholic acid
C26H43NO5 (449.31410680000005)
Glycohyodeoxycholic acid is a major metabolite of Hyodeoxycholic acid in humans. Glycohyodeoxycholic acid has preventative effects on gallstone formation[1][2].
Glycochenodeoxycholate
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids D013501 - Surface-Active Agents > D003902 - Detergents Glycochenodeoxycholic acid (Chenodeoxycholylglycine) is a bile acid formed in the liver from chenodeoxycholate and glycine. It acts as a detergent to solubilize fats for absorption and is itself absorbed. Glycochenodeoxycholic acid (Chenodeoxycholylglycine) induces hepatocyte apoptosis[1][2].
Glycodeoxycholate
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids D013501 - Surface-Active Agents > D003902 - Detergents Glycodeoxycholic Acid is an endogenous metabolite. Glycodeoxycholic Acid is an endogenous metabolite.
Notoamide C
C26H31N3O4 (449.23144460000003)
A notoamide that is 7,7-dimethyl-1,7-dihydropyrano[2,3-g]indol-2(3H)-one which is substituted at position 3 by 3-methylbut-1-en-3-yl and [(3S,8aS)-1,4-dioxooctahydropyrrolo[1,2-a]pyrazin-3-yl]methyl groups (the all-S stereoisomer). Isolated from a mussel-derived Aspergillus species.
methyl (2E,8E)-9-[3a-hydroxy-6,7-dimethyl-1-(2-methylpropyl)-3-oxo-2,4,7,7a-tetrahydro-1H-isoindol-4-yl]-4,5-dihydroxy-8-methylnona-2,8-dienoate
(15aR)-(15ar,19acC13)-15a,6,8,9,55,6-hexahydro-54H-10-aza-1(2,9a)-dibenzofurana-5(1,3)-pyrimidina-cyclotridecaphane-2t,12t-diene-17,4,11-trione|21,25-methanediyl-lunarine|Alkaloid LBX|alkaloid LBX (Lunaria)
C26H31N3O4 (449.23144460000003)
(1alpha,7beta,14alpha,16beta)-20-ethyl-8-hydroxy-1,16-dimethoxy-4-methylaconitan-14-yl acetate|14-acetoxyscaconine
notoamide D
C26H31N3O4 (449.23144460000003)
An organic heterohexacyclic compound isolated from a mussel-derived Aspergillus species that is 3,6b,7,7a,10,11,12,12a,14a,15-decahydro-8H,13H-pyrano[2,3-g]pyrrolo[1,2:4,5]pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-8,13-dione which is substituted by two methyl groups at position 3, a hydroxy group at the 6b position, and a 2-methylbut-3-en-2-yl group at the 14a position (the 6bR, 7aS, 12aS, 14aS stereoisomer).
Norerythrostachaldin-3beta-acetat|Norerythrostachaldine 3beta-acetate
methyl (2E,8E)-9-[3a-hydroxy-6,7-dimethyl-1-(2-methylpropyl)-3-oxo-2,4,7,7a-tetrahydro-1H-isoindol-4-yl]-4,5-dihydroxy-8-methylnona-2,8-dienoate
C26H31N3O4_6b-Hydroxy-2,2-dimethyl-14a-(2-methyl-3-buten-2-yl)-2,6b,7,7a,10,11,12,12a,14a,15-decahydro-8H,13H-pyrano[3,2-g]pyrrolo[1,2:4,5]pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-8,13-dione
C26H31N3O4 (449.23144460000003)
Glycochenodeoxycholic acid
C26H43NO5 (449.31410680000005)
A bile acid glycine conjugate having 3alpha,7alpha-dihydroxy-5beta-cholan-24-oyl as the bile acid component. Chenodeoxycholic acid glycine conjugate is an acyl glycine and a bile acid-glycine conugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID:16949895). This compound usually exists as the sodium salt and acts as a detergent to solubilize fats for absorption and is itself absorbed. It is a cholagogue and choleretic. [HMDB] Glycochenodeoxycholic acid (Chenodeoxycholylglycine) is a bile acid formed in the liver from chenodeoxycholate and glycine. It acts as a detergent to solubilize fats for absorption and is itself absorbed. Glycochenodeoxycholic acid (Chenodeoxycholylglycine) induces hepatocyte apoptosis[1][2].
deoxycholic acid glycine conjugate
C26H43NO5 (449.31410680000005)
Glycodeoxycholic acid
C26H43NO5 (449.31410680000005)
CONFIDENCE standard compound; INTERNAL_ID 54
Glycoursodeoxycholic acid
C26H43NO5 (449.31410680000005)
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts A bile acid glycine conjugate derived from ursoodeoxycholic acid. D005765 - Gastrointestinal Agents > D002793 - Cholic Acids CONFIDENCE standard compound; INTERNAL_ID 55 Glycoursodeoxycholic acid, a acyl glycine and a bile acid-glycine conjugate, is a metabolite of ursodeoxycholic acid.
Glycohyodeoxycholic acid
C26H43NO5 (449.31410680000005)
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids CONFIDENCE standard compound; INTERNAL_ID 82 Glycohyodeoxycholic acid is a major metabolite of Hyodeoxycholic acid in humans. Glycohyodeoxycholic acid has preventative effects on gallstone formation[1][2].
N-[(3a,5b,7a)-3,7-Dihydroxy-24-oxocholan-24-yl]glycine
C26H43NO5 (449.31410680000005)
BA-130-150. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-130-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-130-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-130-30. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.
N-[(3alpha,5beta,7beta)-3,7-Dihydroxy-24-oxocholan-24-yl]glycine
C26H43NO5 (449.31410680000005)
BA-131-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-131-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.
methyl (2E,8E)-9-[3a-hydroxy-6,7-dimethyl-1-(2-methylpropyl)-3-oxo-2,4,7,7a-tetrahydro-1H-isoindol-4-yl]-4,5-dihydroxy-8-methylnona-2,8-dienoate [IIN-based on: CCMSLIB00000846918]
methyl (2E,8E)-9-[3a-hydroxy-6,7-dimethyl-1-(2-methylpropyl)-3-oxo-2,4,7,7a-tetrahydro-1H-isoindol-4-yl]-4,5-dihydroxy-8-methylnona-2,8-dienoate [IIN-based: Match]
methyl (2E,8E)-9-[3a-hydroxy-6,7-dimethyl-1-(2-methylpropyl)-3-oxo-2,4,7,7a-tetrahydro-1H-isoindol-4-yl]-4,5-dihydroxy-8-methylnona-2,8-dienoate [IIN-based on: CCMSLIB00000846920]
Glycochenodeoxycholic acid; LC-tDDA; CE10
C26H43NO5 (449.31410680000005)
Glycochenodeoxycholic acid; LC-tDDA; CE20
C26H43NO5 (449.31410680000005)
Glycochenodeoxycholic acid; LC-tDDA; CE30
C26H43NO5 (449.31410680000005)
Glycochenodeoxycholic acid; LC-tDDA; CE40
C26H43NO5 (449.31410680000005)
Glycochenodeoxycholic acid [M+H-H4O2]+; AIF; CE0; CorrDec
C26H43NO5 (449.31410680000005)
Glycochenodeoxycholic acid [M+H-H4O2]+; AIF; CE10; CorrDec
C26H43NO5 (449.31410680000005)
Glycochenodeoxycholic acid [M+H-H4O2]+; AIF; CE30; CorrDec
C26H43NO5 (449.31410680000005)
Glycochenodeoxycholic acid [M+H-H2O]+; AIF; CE0; CorrDec
C26H43NO5 (449.31410680000005)
Glycochenodeoxycholic acid [M+H-H2O]+; AIF; CE10; CorrDec
C26H43NO5 (449.31410680000005)
Glycochenodeoxycholic acid [M+H-H2O]+; AIF; CE30; CorrDec
C26H43NO5 (449.31410680000005)
Glycochenodeoxycholic acid; AIF; CE0; CorrDec
C26H43NO5 (449.31410680000005)
Glycochenodeoxycholic acid; AIF; CE10; CorrDec
C26H43NO5 (449.31410680000005)
Glycochenodeoxycholic acid; AIF; CE30; CorrDec
C26H43NO5 (449.31410680000005)
Glycochenodeoxycholic acid; AIF; CE0; MS2Dec
C26H43NO5 (449.31410680000005)
Glycochenodeoxycholic acid; AIF; CE10; MS2Dec
C26H43NO5 (449.31410680000005)
Glycochenodeoxycholic acid; AIF; CE30; MS2Dec
C26H43NO5 (449.31410680000005)
Glycochenodeoxycholic acid [M+H-H2O]+; AIF; CE0; MS2Dec
C26H43NO5 (449.31410680000005)
Glycochenodeoxycholic acid [M+H-H2O]+; AIF; CE10; MS2Dec
C26H43NO5 (449.31410680000005)
Glycochenodeoxycholic acid [M+H-H2O]+; AIF; CE30; MS2Dec
C26H43NO5 (449.31410680000005)
Glycochenodeoxycholic acid [M+H-H4O2]+; AIF; CE0; MS2Dec
C26H43NO5 (449.31410680000005)
Glycochenodeoxycholic acid [M+H-H4O2]+; AIF; CE10; MS2Dec
C26H43NO5 (449.31410680000005)
Glycochenodeoxycholic acid [M+H-H4O2]+; AIF; CE30; MS2Dec
C26H43NO5 (449.31410680000005)
((4R)-4-((3R,5R,9S,10S,12R,13R,14S,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)glycine
C26H43NO5 (449.31410680000005)
Ala Phe Gly Arg
Ala Phe Asn Val
Ala Phe Arg Gly
Ala Phe Val Asn
Ala Gly Phe Arg
Ala Gly Arg Phe
Ala Lys Met Thr
C18H35N5O6S (449.23079300000006)
Ala Lys Thr Met
C18H35N5O6S (449.23079300000006)
Ala Met Lys Thr
C18H35N5O6S (449.23079300000006)
Ala Met Thr Lys
C18H35N5O6S (449.23079300000006)
Ala Asn Phe Val
Ala Asn Val Phe
Ala Arg Phe Gly
Ala Arg Gly Phe
Ala Thr Lys Met
C18H35N5O6S (449.23079300000006)
Ala Thr Met Lys
C18H35N5O6S (449.23079300000006)
Ala Val Phe Asn
Ala Val Asn Phe
Cys Ile Lys Ser
C18H35N5O6S (449.23079300000006)
Cys Ile Ser Lys
C18H35N5O6S (449.23079300000006)
Cys Lys Ile Ser
C18H35N5O6S (449.23079300000006)
Cys Lys Leu Ser
C18H35N5O6S (449.23079300000006)
Cys Lys Ser Ile
C18H35N5O6S (449.23079300000006)
Cys Lys Ser Leu
C18H35N5O6S (449.23079300000006)
Cys Lys Thr Val
C18H35N5O6S (449.23079300000006)
Cys Lys Val Thr
C18H35N5O6S (449.23079300000006)
Cys Leu Lys Ser
C18H35N5O6S (449.23079300000006)
Cys Leu Ser Lys
C18H35N5O6S (449.23079300000006)
Cys Ser Ile Lys
C18H35N5O6S (449.23079300000006)
Cys Ser Lys Ile
C18H35N5O6S (449.23079300000006)
Cys Ser Lys Leu
C18H35N5O6S (449.23079300000006)
Cys Ser Leu Lys
C18H35N5O6S (449.23079300000006)
Cys Thr Lys Val
C18H35N5O6S (449.23079300000006)
Cys Thr Val Lys
C18H35N5O6S (449.23079300000006)
Cys Val Lys Thr
C18H35N5O6S (449.23079300000006)
Cys Val Thr Lys
C18H35N5O6S (449.23079300000006)
Phe Ala Gly Arg
Phe Ala Asn Val
Phe Ala Arg Gly
Phe Ala Val Asn
Phe Gly Ala Arg
Phe Gly Ile Asn
Phe Gly Lys Val
C22H35N5O5 (449.26380600000005)
Phe Gly Leu Asn
Phe Gly Asn Ile
Phe Gly Asn Leu
Phe Gly Gln Val
Phe Gly Arg Ala
Phe Gly Val Lys
C22H35N5O5 (449.26380600000005)
Phe Gly Val Gln
Phe Ile Gly Asn
Phe Ile Asn Gly
Phe Lys Gly Val
C22H35N5O5 (449.26380600000005)
Phe Lys Val Gly
C22H35N5O5 (449.26380600000005)
Phe Leu Gly Asn
Phe Leu Asn Gly
Phe Asn Ala Val
Phe Asn Gly Ile
Phe Asn Gly Leu
Phe Asn Ile Gly
Phe Asn Leu Gly
Phe Asn Val Ala
Phe Gln Gly Val
Phe Gln Val Gly
Phe Arg Ala Gly
Phe Arg Gly Ala
Phe Val Ala Asn
Phe Val Gly Lys
C22H35N5O5 (449.26380600000005)
Phe Val Gly Gln
Phe Val Lys Gly
C22H35N5O5 (449.26380600000005)
Phe Val Asn Ala
Phe Val Gln Gly
Gly Ala Phe Arg
Gly Ala Arg Phe
Gly Phe Ala Arg
Gly Phe Ile Asn
Gly Phe Lys Val
C22H35N5O5 (449.26380600000005)
Gly Phe Leu Asn
Gly Phe Asn Ile
Gly Phe Arg Ala
Gly Phe Val Lys
C22H35N5O5 (449.26380600000005)
Gly Lys Phe Val
C22H35N5O5 (449.26380600000005)
Gly Lys Val Phe
C22H35N5O5 (449.26380600000005)
Gly Arg Ala Phe
Gly Arg Phe Ala
Gly Val Phe Lys
C22H35N5O5 (449.26380600000005)
Gly Val Lys Phe
C22H35N5O5 (449.26380600000005)
Ile Cys Lys Ser
C18H35N5O6S (449.23079300000006)
Ile Cys Ser Lys
C18H35N5O6S (449.23079300000006)
Ile Lys Cys Ser
C18H35N5O6S (449.23079300000006)
Ile Lys Ser Cys
C18H35N5O6S (449.23079300000006)
Ile Ser Cys Lys
C18H35N5O6S (449.23079300000006)
Ile Ser Lys Cys
C18H35N5O6S (449.23079300000006)
Lys Ala Met Thr
C18H35N5O6S (449.23079300000006)
Lys Ala Thr Met
C18H35N5O6S (449.23079300000006)
Lys Cys Ile Ser
C18H35N5O6S (449.23079300000006)
Lys Cys Leu Ser
C18H35N5O6S (449.23079300000006)
Lys Cys Ser Ile
C18H35N5O6S (449.23079300000006)
Lys Cys Ser Leu
C18H35N5O6S (449.23079300000006)
Lys Cys Thr Val
C18H35N5O6S (449.23079300000006)
Lys Cys Val Thr
C18H35N5O6S (449.23079300000006)
Lys Phe Gly Val
C22H35N5O5 (449.26380600000005)
Lys Phe Val Gly
C22H35N5O5 (449.26380600000005)
Lys Gly Phe Val
C22H35N5O5 (449.26380600000005)
Lys Gly Val Phe
C22H35N5O5 (449.26380600000005)
Lys Ile Cys Ser
C18H35N5O6S (449.23079300000006)
Lys Ile Ser Cys
C18H35N5O6S (449.23079300000006)
Lys Leu Cys Ser
C18H35N5O6S (449.23079300000006)
Lys Leu Ser Cys
C18H35N5O6S (449.23079300000006)
Lys Met Ala Thr
C18H35N5O6S (449.23079300000006)
Lys Met Thr Ala
C18H35N5O6S (449.23079300000006)
Lys Ser Cys Ile
C18H35N5O6S (449.23079300000006)
Lys Ser Cys Leu
C18H35N5O6S (449.23079300000006)
Lys Ser Ile Cys
C18H35N5O6S (449.23079300000006)
Lys Ser Leu Cys
C18H35N5O6S (449.23079300000006)
Lys Thr Ala Met
C18H35N5O6S (449.23079300000006)
Lys Thr Cys Val
C18H35N5O6S (449.23079300000006)
Lys Thr Met Ala
C18H35N5O6S (449.23079300000006)
Lys Thr Thr Thr
Lys Thr Val Cys
C18H35N5O6S (449.23079300000006)
Lys Val Cys Thr
C18H35N5O6S (449.23079300000006)
Lys Val Phe Gly
C22H35N5O5 (449.26380600000005)
Lys Val Gly Phe
C22H35N5O5 (449.26380600000005)
Lys Val Thr Cys
C18H35N5O6S (449.23079300000006)
Leu Cys Lys Ser
C18H35N5O6S (449.23079300000006)
Leu Cys Ser Lys
C18H35N5O6S (449.23079300000006)
Leu Lys Cys Ser
C18H35N5O6S (449.23079300000006)
Leu Lys Ser Cys
C18H35N5O6S (449.23079300000006)
Leu Ser Cys Lys
C18H35N5O6S (449.23079300000006)
Leu Ser Lys Cys
C18H35N5O6S (449.23079300000006)
Met Ala Lys Thr
C18H35N5O6S (449.23079300000006)
Met Ala Thr Lys
C18H35N5O6S (449.23079300000006)
Met Lys Ala Thr
C18H35N5O6S (449.23079300000006)
Met Lys Thr Ala
C18H35N5O6S (449.23079300000006)
Met Thr Ala Lys
C18H35N5O6S (449.23079300000006)
Met Thr Lys Ala
C18H35N5O6S (449.23079300000006)
Arg Ala Phe Gly
Arg Ala Gly Phe
Arg Phe Ala Gly
Arg Phe Gly Ala
Arg Gly Ala Phe
Arg Gly Phe Ala
Ser Cys Ile Lys
C18H35N5O6S (449.23079300000006)
Ser Cys Lys Ile
C18H35N5O6S (449.23079300000006)
Ser Cys Lys Leu
C18H35N5O6S (449.23079300000006)
Ser Cys Leu Lys
C18H35N5O6S (449.23079300000006)
Ser Ile Cys Lys
C18H35N5O6S (449.23079300000006)
Ser Ile Lys Cys
C18H35N5O6S (449.23079300000006)
Ser Lys Cys Ile
C18H35N5O6S (449.23079300000006)
Ser Lys Cys Leu
C18H35N5O6S (449.23079300000006)
Ser Lys Ile Cys
C18H35N5O6S (449.23079300000006)
Ser Lys Leu Cys
C18H35N5O6S (449.23079300000006)
Ser Leu Cys Lys
C18H35N5O6S (449.23079300000006)
Ser Leu Lys Cys
C18H35N5O6S (449.23079300000006)
Thr Ala Lys Met
C18H35N5O6S (449.23079300000006)
Thr Ala Met Lys
C18H35N5O6S (449.23079300000006)
Thr Cys Lys Val
C18H35N5O6S (449.23079300000006)
Thr Cys Val Lys
C18H35N5O6S (449.23079300000006)
Thr Lys Ala Met
C18H35N5O6S (449.23079300000006)
Thr Lys Cys Val
C18H35N5O6S (449.23079300000006)
Thr Lys Met Ala
C18H35N5O6S (449.23079300000006)
Thr Lys Thr Thr
Thr Lys Val Cys
C18H35N5O6S (449.23079300000006)
Thr Met Ala Lys
C18H35N5O6S (449.23079300000006)
Thr Met Lys Ala
C18H35N5O6S (449.23079300000006)
Thr Thr Lys Thr
Thr Thr Thr Lys
Thr Val Cys Lys
C18H35N5O6S (449.23079300000006)
Thr Val Lys Cys
C18H35N5O6S (449.23079300000006)
Val Cys Lys Thr
C18H35N5O6S (449.23079300000006)
Val Cys Thr Lys
C18H35N5O6S (449.23079300000006)
Val Phe Gly Lys
C22H35N5O5 (449.26380600000005)
Val Phe Lys Gly
C22H35N5O5 (449.26380600000005)
Val Gly Phe Lys
C22H35N5O5 (449.26380600000005)
Val Gly Lys Phe
C22H35N5O5 (449.26380600000005)
Val Lys Cys Thr
C18H35N5O6S (449.23079300000006)
Val Lys Phe Gly
C22H35N5O5 (449.26380600000005)
Val Lys Gly Phe
C22H35N5O5 (449.26380600000005)
Val Lys Thr Cys
C18H35N5O6S (449.23079300000006)
Val Thr Cys Lys
C18H35N5O6S (449.23079300000006)
Val Thr Lys Cys
C18H35N5O6S (449.23079300000006)
Glycoursodeoxycholate
C26H43NO5 (449.31410680000005)
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids Glycoursodeoxycholic acid, a acyl glycine and a bile acid-glycine conjugate, is a metabolite of ursodeoxycholic acid.
Glycodeoxycholate
C26H43NO5 (449.31410680000005)
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids D013501 - Surface-Active Agents > D003902 - Detergents A bile acid glycine conjugate of deoxycholic acid. Glycodeoxycholic Acid is an endogenous metabolite. Glycodeoxycholic Acid is an endogenous metabolite.
Cadabicine methyl ether
C26H31N3O4 (449.23144460000003)
6b-hydroxy-2,2-dimethyl-14a-(2-methylbut-3-en-2-yl)-2,6b,7,7a,10,11,12,12a,14a,15-decahydro-8H,13H-pyrano[3,2-g]pyrrolo[1,2:4,5]pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-8,13-dione
C26H31N3O4 (449.23144460000003)
3-(aminomethyl)-3,5,5-trimethylcyclohexan-1-amine,azepan-2-one,benzene-1,3-dicarboxylic acid
Onapristone
C29H39NO3 (449.29297840000004)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C1891 - Progesterone Antagonist D012102 - Reproductive Control Agents > D005299 - Fertility Agents D000970 - Antineoplastic Agents
(2S)-1,3-diphenylpropyl 1-(3,3-diMethyl-2-oxopentanoyl)piperidine-2-carboxylate
C28H35NO4 (449.25659500000006)
4-(n-Butoxy)phenyl-4-trans-heptylcyclohexylbenzoate
C30H41O3- (449.30555360000005)
SNC80
SNC80 (NIH 10815) is a potent, highly selective and non-peptide δ-opioid receptor agonist with a Ki of 1.78 nM and an IC50 of 2.73 nM. SNC80 also selectively activates μ-δ heteromer in HEK293 cells with an EC50 of 52.8 nM. SNC80 shows antinociceptive, antihyperalgesic and antidepressant‐like effects. SNC80 has the potential for multiple headache disorders treatment[1][2][3][4][5][6].
(5α,18R)-18-[(2R)-2-Hydroxy-2-pentanyl]-6-methoxy-17-methyl-18,19 -dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol hydrochloride (1:1)
C25H36ClNO4 (449.2332726000001)
Nicodicosapent
Nicodicosapent is a fatty acid niacin conjugate that is also an inhibitor of the sterol regulatory element binding protein (SREBP), a key regulator of cholesterol metabolism proteins such as PCSK9, HMG-CoA reductase, ATP citrate lyase, and NPC1L1.
N-[(1R,2R)-2-aMinocyclohexyl]-N-(8α,9S)-cinchonan-9-yl-thiourea
C26H35N5S (449.26130300000005)
8-cyclopentyl-6-(1-hydroxyethyl)-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one
1-(1-methylbenzoimidazol-2-yl)-N,N-bis[(1-methylbenzoimidazol-2-yl)methyl]methanamine
Asoprisnil
C28H35NO4 (449.25659500000006)
C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C1891 - Progesterone Antagonist
2-[[(4R)-4-[(3R,5S,7S,10S,13R,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid
C26H43NO5 (449.31410680000005)
Chenodeoxycholic acid glycine conjugate
C26H43NO5 (449.31410680000005)
N-(3-((Hydroxyamino)carbonyl)-2-benzyl-1-oxoprolyl)-L-isoleucine-L-leucine
C23H35N3O6 (449.25257300000004)
2-acetamido-N-[1-(3-cyano-4,6-dimethyl-2-pyridinyl)-4-piperidinyl]-3-(3-methoxyphenyl)propanamide
N-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcyclohexanecarboxamide
N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcyclohexanecarboxamide
N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcyclohexanecarboxamide
N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcyclohexanecarboxamide
1-[(1R)-1-(hydroxymethyl)-7-methoxy-2-[(4-methoxyphenyl)methyl]-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]ethanone
C26H31N3O4 (449.23144460000003)
N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcyclohexanecarboxamide
N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcyclohexanecarboxamide
(3aR,4R,9bS)-N-cyclohexyl-4-(hydroxymethyl)-8-(4-methoxyphenyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinoline-1-carboxamide
(10S,11R)-10-[(dimethylamino)methyl]-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-14-one
(3aR,4S,9bS)-N-cyclohexyl-4-(hydroxymethyl)-8-(4-methoxyphenyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinoline-1-carboxamide
(10R,11S)-10-[(dimethylamino)methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-14-one
2-[(3R,6aS,8R,10aS)-1-[(2-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-methyl-1-piperazinyl)ethanone
N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcyclohexanecarboxamide
N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcyclohexanecarboxamide
N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcyclohexanecarboxamide
2-[(3S,6aR,8S,10aR)-1-(2-fluorobenzoyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-methylpiperazin-1-yl)ethanone
2-[(3R,6aR,8S,10aR)-1-[(2-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-methyl-1-piperazinyl)ethanone
2-[(3S,6aS,8R,10aS)-1-(2-fluorobenzoyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-methylpiperazin-1-yl)ethanone
((4R)-4-((3R,5R,9S,10S,12R,13R,14S,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)glycine
C26H43NO5 (449.31410680000005)
N-[(5R,6R,9S)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C23H35N3O6 (449.25257300000004)
N-[(5R,6S,9R)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C23H35N3O6 (449.25257300000004)
N-[(5S,6R,9R)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C23H35N3O6 (449.25257300000004)
(10R,11R)-10-[(dimethylamino)methyl]-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-14-one
2-[(3R,6aS,8S,10aS)-1-[(2-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-methyl-1-piperazinyl)ethanone
2-[(3S,6aR,8R,10aR)-1-[(2-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-methyl-1-piperazinyl)ethanone
2-[(3S,6aS,8S,10aS)-1-[(2-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-methyl-1-piperazinyl)ethanone
(10S,11S)-10-[(dimethylamino)methyl]-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-14-one
[(1R)-2-(cyclopropylmethyl)-1-[(4-fluorophenyl)methyl]-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C27H32FN3O2 (449.24784239999997)
N-[(5S,6S,9S)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C23H35N3O6 (449.25257300000004)
N-[(5R,6S,9S)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C23H35N3O6 (449.25257300000004)
N-[(5S,6S,9R)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C23H35N3O6 (449.25257300000004)
N-[(5S,6R,9S)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C23H35N3O6 (449.25257300000004)
N-[(5R,6R,9R)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C23H35N3O6 (449.25257300000004)
(10S,11R)-10-[(dimethylamino)methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-14-one
2-[(3R,6aR,8R,10aR)-1-[(2-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-methyl-1-piperazinyl)ethanone
(3aS,4R,9bR)-N-cyclohexyl-4-(hydroxymethyl)-8-(4-methoxyphenyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinoline-1-carboxamide
(10R,11R)-10-[(dimethylamino)methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-14-one
(10S,11S)-10-[(dimethylamino)methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-14-one
2-(dimethylamino)-1-[(1S)-1-(hydroxymethyl)-7-methoxy-2-(pyridin-4-ylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]ethanone
2-(dimethylamino)-1-[(1R)-1-(hydroxymethyl)-7-methoxy-2-(pyridin-4-ylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]ethanone
[(1S)-2-(cyclopropylmethyl)-1-[(4-fluorophenyl)methyl]-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C27H32FN3O2 (449.24784239999997)
1-[(1S)-1-(hydroxymethyl)-7-methoxy-2-[(3-methoxyphenyl)methyl]-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-1-propanone
C26H31N3O4 (449.23144460000003)
1-[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-(phenylmethyl)-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone
C26H31N3O4 (449.23144460000003)
1-[(1S)-1-(hydroxymethyl)-7-methoxy-2-[(4-methoxyphenyl)methyl]-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]ethanone
C26H31N3O4 (449.23144460000003)
1-[(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-(phenylmethyl)-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone
C26H31N3O4 (449.23144460000003)
2-aminoethyl [3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-hydroxypropyl] hydrogen phosphate
C22H44NO6P (449.29060940000005)
[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (9Z,12Z)-hexadeca-9,12-dienoate
C21H40NO7P (449.2542260000001)
(E)-3-hydroxy-2-(2-hydroxydodecanoylamino)dec-4-ene-1-sulfonic acid
C22H43NO6S (449.28109380000006)
3-hydroxy-2-[[(Z)-2-hydroxydodec-5-enoyl]amino]decane-1-sulfonic acid
C22H43NO6S (449.28109380000006)
3-Hydroxy-2-(undecanoylamino)dodecane-1-sulfonic acid
C23H47NO5S (449.31747720000004)
2-(Decanoylamino)-3-hydroxytridecane-1-sulfonic acid
C23H47NO5S (449.31747720000004)
2-(Dodecanoylamino)-3-hydroxyundecane-1-sulfonic acid
C23H47NO5S (449.31747720000004)
3-Hydroxy-2-(tridecanoylamino)decane-1-sulfonic acid
C23H47NO5S (449.31747720000004)
2-[4-[(3R,5S,7R,8R,9S,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid
C26H43NO5 (449.31410680000005)
2-[4-[(3R,5S,7S,8R,9S,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid
C26H43NO5 (449.31410680000005)
2-[4-[(3R,5R,8R,9S,12S,14S,17R)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid
C26H43NO5 (449.31410680000005)
2-[hydroxy-[(4E,8E)-3-hydroxy-2-(propanoylamino)trideca-4,8-dienoxy]phosphoryl]oxyethyl-trimethylazanium
C21H42N2O6P+ (449.27803420000004)
2-[[(4E,8E)-2-acetamido-3-hydroxytetradeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C21H42N2O6P+ (449.27803420000004)
2-[[(4E,8E)-2-(butanoylamino)-3-hydroxydodeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C21H42N2O6P+ (449.27803420000004)
gentamycin C1a
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic
2-[4-(3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoylamino]acetic acid
C26H43NO5 (449.31410680000005)
2-[4-(3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoylamino]acetic acid
C26H43NO5 (449.31410680000005)
8-ethyl-2,16-dihydroxy-13,15-dimethoxy-5-oxa-8-azaheptacyclo[8.7.2.1¹⁴,¹⁷.0¹,⁹.0⁴,⁶.0⁶,¹⁸.0¹¹,¹⁶]icosan-11-yl acetate
C24H35NO7 (449.24134000000004)
(1s,2r,3r,4s,5s,6s,8s,9s,10r,13s,16s,17r)-8-ethoxy-11-ethyl-6,16-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-ol
C26H43NO5 (449.31410680000005)
(3r,3ar,4r,6as,10s,12r,15r)-3-benzyl-1,12,15-trihydroxy-4,5,10,12-tetramethyl-3h,3ah,4h,6ah,9h,10h,15h-cycloundeca[d]isoindol-11-one
C28H35NO4 (449.25659500000006)
(1s,2r,3r,4s,5s,6s,8r,12r,13s,16r,19s,20r,21s)-14-ethyl-6,19,21-trimethoxy-16-methyl-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosan-4-ol
11-hydroperoxy-5,6,16-trihydroxy-9,12,13-trimethyl-14-(2-methylpropyl)-5h,6h,7h,8h,10ah,11h,13ah,14h-oxacyclododeca[2,3-d]isoindol-2-one
C24H35NO7 (449.24134000000004)
(1s,2r,3s,4r,5s,6r,8r,9r,10s,13s,16r,17s)-11-ethyl-2,8-dihydroxy-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate
methyl (1r,2s,4ar,4bs,8r,8ar,10ar)-7-{2-[2-(dimethylamino)ethoxy]-2-oxoethylidene}-2-hydroxy-1,4a,8-trimethyl-9-oxo-decahydrophenanthrene-1-carboxylate
(1s,2s,4r,5r,7s,8s,12s,13s,16r,19s,20r,21s,22s)-14-ethyl-5,19,22-trimethoxy-16-methyl-9,11-dioxa-14-azaheptacyclo[10.7.2.1⁴,⁷.0¹,¹³.0²,⁷.0⁸,¹².0¹⁶,²⁰]docosan-21-ol
11-ethyl-8-hydroxy-6-methoxy-13-methyl-16-(methylperoxy)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate
methyl (4s,5r)-9-[(1s,3ar,4s,7s,7as)-3,3a-dihydroxy-6,7-dimethyl-1-(2-methylpropyl)-1,4,7,7a-tetrahydroisoindol-4-yl]-4,5-dihydroxy-8-methylnona-2,8-dienoate
(1s,2r,3r,4s,5s,6s,8r,12s,13s,16r,19s,20r,21s)-14-ethyl-6,19,21-trimethoxy-16-methyl-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosan-4-ol
14-acetylgenicunine b
{"Ingredient_id": "HBIN001357","Ingredient_name": "14-acetylgenicunine b","Alias": "NA","Ingredient_formula": "C25H39NO6","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "396","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8-acetylexcelsine
C24H35NO7 (449.24134000000004)
{"Ingredient_id": "HBIN013610","Ingredient_name": "8-acetylexcelsine","Alias": "NA","Ingredient_formula": "C24H35NO7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "392","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(1s,2r,3r,4s,5r,6s,8r,9r,10r,13r,16s,17r,18r)-4,6,8,16-tetramethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-18-yl acetate
9,10-dihydroxy-7,15-dimethyl-20-(octa-2,4-dien-1-yl)-1-azacycloicosa-3,5,7,11,13,15,17-heptaen-2-one
C29H39NO3 (449.29297840000004)
(5s,6s)-6-[(1e,3r,4r,6r,7z,9z)-3-(2-aminoethyl)-3,4,6-trihydroxy-10-[(1r,3s)-3-hydroxycyclohexyl]deca-1,7,9-trien-1-yl]-5-ethyl-5,6-dihydropyran-2-one
(2s,3r)-n-[(2s)-5-carbamimidamido-1-oxopentan-2-yl]-2-{[1,2-dihydroxy-4-(4-hydroxyphenyl)butylidene]amino}-3-methylpentanimidic acid
C22H35N5O5 (449.26380600000005)
(1r,2s,3s,6r,7s,8r,11s,14r,15s,17s)-8-benzyl-10-hydroxy-17-(hydroxymethyl)-1,5,6-trimethyl-19-oxa-9-azapentacyclo[13.3.1.0²,¹⁴.0³,¹¹.0⁷,¹¹]nonadeca-4,9-dien-12-one
C28H35NO4 (449.25659500000006)
(1r,3e,5r,7r,9e,11s,12r,14s,15r,16s,17r)-17-benzyl-5,19-dihydroxy-5,7,14,15-tetramethyl-13-oxa-18-azatetracyclo[9.8.0.0¹,¹⁶.0¹²,¹⁴]nonadeca-3,9,18-trien-2-one
C28H35NO4 (449.25659500000006)
n-(5-carbamimidamido-1-oxopentan-2-yl)-2-{[1,2-dihydroxy-4-(4-hydroxyphenyl)butylidene]amino}-3-methylpentanimidic acid
C22H35N5O5 (449.26380600000005)
(5s,6r,10as,11s,13as,14s,16as)-11-hydroperoxy-5,6,16-trihydroxy-9,12,13-trimethyl-14-(2-methylpropyl)-5h,6h,7h,8h,10ah,11h,13ah,14h-oxacyclododeca[2,3-d]isoindol-2-one
C24H35NO7 (449.24134000000004)
(5s,6r,7s,10as,13s,13as,14s,16as)-14-benzyl-6,16-dihydroxy-5,7,12,13-tetramethyl-5h,6h,7h,8h,10ah,13h,13ah,14h-oxacyclododeca[3,2-d]isoindol-2-one
C28H35NO4 (449.25659500000006)
(3r,3as,4r,6ar,10r,12r,15as)-3-benzyl-1,12-dihydroxy-5-(hydroxymethyl)-4,10,12-trimethyl-3h,3ah,4h,6ah,9h,10h,11h-cycloundeca[d]isoindol-15-one
C28H35NO4 (449.25659500000006)
(8e,22e)-4-methoxy-2-oxa-11,16,20-triazatricyclo[22.2.2.1³,⁷]nonacosa-1(26),3(29),4,6,8,10,20,22,24,27-decaene-10,21-diol
C26H31N3O4 (449.23144460000003)
n-{5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl}-2-[(1-hydroxyethylidene)amino]-4-methylpentanimidic acid
(1s,2r,3r,4s,5r,6s,8r,12s,16r,19s,20r,21s)-14-ethyl-4,6,19-trimethoxy-16-methyl-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosan-21-ol
(1r,13s,16s,22s)-1-hydroxy-7,7-dimethyl-13-(2-methylbut-3-en-2-yl)-8-oxa-12,14,20-triazahexacyclo[11.10.0.0²,¹¹.0⁴,⁹.0¹⁴,²².0¹⁶,²⁰]tricosa-2,4(9),5,10-tetraene-15,21-dione
C26H31N3O4 (449.23144460000003)
(1r,2s,3s,4s,5s,6r,8r,9r,10s,13r,16r,17s)-11-ethyl-8,16-dihydroxy-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate
methyl 7-{2-[2-(dimethylamino)ethoxy]-2-oxoethylidene}-9-hydroxy-1,4a,8-trimethyl-10-oxo-decahydrophenanthrene-1-carboxylate
(1s,2r,3r,4s,5s,6s,8r,9r,10s,13r,16s,17r)-11-ethyl-8,16-dihydroxy-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate
17-benzyl-5,19-dihydroxy-5,7,14,15-tetramethyl-13-oxa-18-azatetracyclo[9.8.0.0¹,¹⁶.0¹²,¹⁴]nonadeca-3,9,18-trien-2-one
C28H35NO4 (449.25659500000006)
14-ethyl-4,6,19-trimethoxy-16-methyl-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosan-21-ol
(3s,8as)-1-hydroxy-3-{[(6s)-7-hydroxy-2,2-dimethyl-6-(2-methylbut-3-en-2-yl)chromeno[7,6-b]pyrrol-6-yl]methyl}-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one
C26H31N3O4 (449.23144460000003)
methyl 7-{2-[2-(dimethylamino)ethoxy]-2-oxoethylidene}-2-hydroxy-1,4a,8-trimethyl-9-oxo-decahydrophenanthrene-1-carboxylate
(5s,7s,10as,13s,13as,14s,16as)-14-benzyl-5,16-dihydroxy-5,7,12,13-tetramethyl-6h,7h,8h,10ah,13h,13ah,14h-oxacyclododeca[3,2-d]isoindol-2-one
C28H35NO4 (449.25659500000006)
{[(4r)-4-[(1r,3as,3br,5ar,7r,9as,9bs,11s,11ar)-7,11-dihydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]-1-hydroxypentylidene]amino}acetic acid
C26H43NO5 (449.31410680000005)
(1s,2r,3r,4s,5r,6s,8s,9s,10r,13s,16s,17r)-11-ethyl-8,16-dihydroxy-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate
(3s,8as)-1-hydroxy-3-{[(6r)-7-hydroxy-2,2-dimethyl-6-(2-methylbut-3-en-2-yl)chromeno[7,6-b]pyrrol-6-yl]methyl}-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one
C26H31N3O4 (449.23144460000003)
14-benzyl-6,16-dihydroxy-5,7,12,13-tetramethyl-5h,6h,7h,8h,10ah,13h,13ah,14h-oxacyclododeca[3,2-d]isoindol-2-one
C28H35NO4 (449.25659500000006)
5-benzyl-3,12,14-trimethyl-2-methylidene-19-oxa-6-azapentacyclo[14.2.1.0⁴,⁸.0⁸,¹⁸.0¹¹,¹⁷]nonadeca-6,12-diene-7,9,10-triol
C28H35NO4 (449.25659500000006)
6-[3-(2-aminoethyl)-3,4,6-trihydroxy-10-(3-hydroxycyclohexyl)deca-1,7,9-trien-1-yl]-5-ethyl-5,6-dihydropyran-2-one
8-ethoxy-11-ethyl-6,16-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-ol
C26H43NO5 (449.31410680000005)
n-[3-chloro-2-(2-hydroxy-3-methylphenyl)prop-2-en-1-yl]-7-methoxy-n-methyltetradec-4-enamide
C26H40ClNO3 (449.26965600000005)
1-hydroxy-7,7-dimethyl-13-(2-methylbut-3-en-2-yl)-8-oxa-12,14,20-triazahexacyclo[11.10.0.0²,¹¹.0⁴,⁹.0¹⁴,²².0¹⁶,²⁰]tricosa-2,4(9),5,10-tetraene-15,21-dione
C26H31N3O4 (449.23144460000003)
8-benzyl-10-hydroxy-17-(hydroxymethyl)-1,5,6-trimethyl-19-oxa-9-azapentacyclo[13.3.1.0²,¹⁴.0³,¹¹.0⁷,¹¹]nonadeca-4,9-dien-12-one
C28H35NO4 (449.25659500000006)
1-hydroxy-7,7-dimethyl-13-(2-methylbut-3-en-2-yl)-6-oxa-12,14,20-triazahexacyclo[11.10.0.0²,¹¹.0⁵,¹⁰.0¹⁴,²².0¹⁶,²⁰]tricosa-2(11),3,5(10),8-tetraene-15,21-dione
C26H31N3O4 (449.23144460000003)
2-(methylamino)ethyl 2-[7-(acetyloxy)-8-formyl-10-hydroxy-1,4b,8-trimethyl-decahydro-1h-phenanthren-2-ylidene]acetate
(1s,2r,3r,4s,5r,6s,8s,9s,10r,13s,16r,17r)-11-ethyl-8,16-dihydroxy-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate
3,3-bis[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-2,6-dihydroxyquinolin-4-one
C29H39NO3 (449.29297840000004)
4-hydroxy-22-oxa-5,10,14-triazapentacyclo[16.9.2.1¹⁰,¹⁴.0¹,²³.0²¹,²⁸]triaconta-2,4,16,18,20,28-hexaene-15,25-dione
C26H31N3O4 (449.23144460000003)
14-ethyl-6,19,21-trimethoxy-16-methyl-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosan-4-ol
14-ethyl-4,6,19-trimethoxy-16-methyl-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosan-20-ol
4-methoxy-2-oxa-11,16,20-triazatricyclo[22.2.2.1³,⁷]nonacosa-1(26),3(29),4,6,8,10,20,22,24,27-decaene-10,21-diol
C26H31N3O4 (449.23144460000003)
(3e,5e,7e,9r,10s,11z,13e,15e,17e,20r)-7,15-dimethyl-20-[(2e,4e)-octa-2,4-dien-1-yl]-1-azacycloicosa-1,3,5,7,11,13,15,17-octaene-2,9,10-triol
C29H39NO3 (449.29297840000004)
11-ethyl-2,8-dihydroxy-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate
3-benzyl-1,12-dihydroxy-5-(hydroxymethyl)-4,10,12-trimethyl-3h,3ah,4h,6ah,9h,10h,11h-cycloundeca[d]isoindol-15-one
C28H35NO4 (449.25659500000006)
(1s,2e,16e,23r)-4-hydroxy-22-oxa-5,10,14-triazapentacyclo[16.9.2.1¹⁰,¹⁴.0¹,²³.0²¹,²⁸]triaconta-2,4,16,18,20,28-hexaene-15,25-dione
C26H31N3O4 (449.23144460000003)
(1r,2s,3r,4s,5r,6s,8s,9s,10r,13r,16s,17r)-11-ethyl-2,8-dihydroxy-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate
(4e,7s)-n-[(2e)-3-chloro-2-(2-hydroxy-3-methylphenyl)prop-2-en-1-yl]-7-methoxy-n-methyltetradec-4-enamide
C26H40ClNO3 (449.26965600000005)
(1r,13s,16s,22s)-1-hydroxy-7,7-dimethyl-13-(2-methylbut-3-en-2-yl)-6-oxa-12,14,20-triazahexacyclo[11.10.0.0²,¹¹.0⁵,¹⁰.0¹⁴,²².0¹⁶,²⁰]tricosa-2(11),3,5(10),8-tetraene-15,21-dione
C26H31N3O4 (449.23144460000003)
(1r,2s,3s,4r,5s,6s,8s,12r,13r,16s,19r,20s,21s)-14-ethyl-4,6,19-trimethoxy-16-methyl-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosan-21-ol
(1r,2s,3s,4s,5r,6s,8r,12r,13s,16s,19s,20r)-4,6,19-trimethoxy-16-(methoxymethyl)-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docos-14-en-3-ol
C24H35NO7 (449.24134000000004)
(3s,3ar,4s,6s,6ar,10s,12s,15as)-3-benzyl-1,6,12-trihydroxy-4,10,12-trimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,11h-cycloundeca[d]isoindol-15-one
C28H35NO4 (449.25659500000006)
(1s,2r,3r,4s,5r,6r,8r,12r,13s,16s,19s,20s)-14-ethyl-4,6,19-trimethoxy-16-methyl-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosan-20-ol
(1s,2r,3r,4r,5r,6s,8s,9s,10r,13s,16s,17r)-11-ethyl-8,16-dihydroxy-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate
(3s,8as)-1-hydroxy-3-{[(3r)-2-hydroxy-7,7-dimethyl-3-(2-methylbut-3-en-2-yl)chromeno[5,6-b]pyrrol-3-yl]methyl}-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one
C26H31N3O4 (449.23144460000003)
1-hydroxy-3-{[7-hydroxy-2,2-dimethyl-6-(2-methylbut-3-en-2-yl)chromeno[7,6-b]pyrrol-6-yl]methyl}-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one
C26H31N3O4 (449.23144460000003)
11-ethyl-8,9,16-trihydroxy-6,18-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-14-en-4-one
C24H35NO7 (449.24134000000004)
(1r,2s,3s,4s,5r,6s,8r,12r,13s,16r,19s,20r)-14-ethyl-4,6,19-trimethoxy-16-methyl-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosan-2-ol
1-hydroxy-3-{[2-hydroxy-7,7-dimethyl-3-(2-methylbut-3-en-2-yl)chromeno[5,6-b]pyrrol-3-yl]methyl}-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one
C26H31N3O4 (449.23144460000003)
(1s,2r,3r,4r,5r,6s,8s,9s,10r,13r,16s,17r)-11-ethyl-8-hydroxy-6-methoxy-13-methyl-16-(methylperoxy)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate
11-ethyl-8,16-dihydroxy-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate
(1r,2s,3s,4r,5r,6s,8r,12r,13s,16s,19s,20r)-4,6,19-trimethoxy-16-(methoxymethyl)-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docos-14-en-3-ol
C24H35NO7 (449.24134000000004)
2-(methylamino)ethyl 2-[(1r,2e,4as,4br,7s,8r,8ar,10s,10as)-7-(acetyloxy)-8-formyl-10-hydroxy-1,4b,8-trimethyl-decahydro-1h-phenanthren-2-ylidene]acetate
(3r,3ar,6s,6ar,10s,12s,15r)-3-benzyl-1,6,15-trihydroxy-4,5,10,12-tetramethyl-3h,3ah,6h,6ah,9h,10h,12h,15h-cycloundeca[d]isoindol-11-one
C28H35NO4 (449.25659500000006)
methyl (1r,2s,4ar,4bs,7z,8r,8ar,10ar)-7-{2-[2-(dimethylamino)ethoxy]-2-oxoethylidene}-2-hydroxy-1,4a,8-trimethyl-9-oxo-decahydrophenanthrene-1-carboxylate
1,6,11,12-tetrahydroxy-13-methoxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,6h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one
4,6,8,16-tetramethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-18-yl acetate
(1s,2r,3r,4s,5r,6s,8r,12s,13s,16r,19s,20r,21s)-14-ethyl-4,6,19-trimethoxy-16-methyl-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosan-21-ol
11-ethyl-4,16-dihydroxy-6,8-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-18-yl acetate
(3s,3ar,6r,6ar,15as)-1,6,11,12-tetrahydroxy-13-methoxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,6h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one
methyl (1s,4ar,4bs,7z,8r,8as,9r,10ar)-7-{2-[2-(dimethylamino)ethoxy]-2-oxoethylidene}-9-hydroxy-1,4a,8-trimethyl-10-oxo-decahydrophenanthrene-1-carboxylate
(1s,3s,4r,5s,8r,9s,10r,11r,14s,16r,18r)-5-benzyl-3,12,14-trimethyl-2-methylidene-19-oxa-6-azapentacyclo[14.2.1.0⁴,⁸.0⁸,¹⁸.0¹¹,¹⁷]nonadeca-6,12-diene-7,9,10-triol
C28H35NO4 (449.25659500000006)
(1s,2r,3s,5r,6s,8r,9s,10s,13s,16s,17r,18s)-11-ethyl-8,9,16-trihydroxy-6,18-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-14-en-4-one
C24H35NO7 (449.24134000000004)
14-ethyl-6,19-dimethoxy-16-(methoxymethyl)-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosan-4-ol
14-ethyl-5,19,22-trimethoxy-16-methyl-9,11-dioxa-14-azaheptacyclo[10.7.2.1⁴,⁷.0¹,¹³.0²,⁷.0⁸,¹².0¹⁶,²⁰]docosan-21-ol
(1s,2s,4s,6s,9r,10s,11s,13s,14r,15s,16s,17s,18s)-8-ethyl-2,16-dihydroxy-13,15-dimethoxy-5-oxa-8-azaheptacyclo[8.7.2.1¹⁴,¹⁷.0¹,⁹.0⁴,⁶.0⁶,¹⁸.0¹¹,¹⁶]icosan-11-yl acetate
C24H35NO7 (449.24134000000004)
(3e,5e,7e,11e,13e,15e,17e)-7,15-dimethyl-20-[(2e,4e)-octa-2,4-dien-1-yl]-1-azacycloicosa-1,3,5,7,11,13,15,17-octaene-2,9,10-triol
C29H39NO3 (449.29297840000004)
[(1s,2r,3r,4r,5s,6s,8s,9s,10r,13s,16r,17r)-11-ethyl-4,8-dihydroxy-6,16-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methyl acetate
3,3-bis(3,7-dimethylocta-2,6-dien-1-yl)-2,6-dihydroxyquinolin-4-one
C29H39NO3 (449.29297840000004)
(1s,2r,3r,4s,5s,6s,8r,12r,13s,16s,19s,20r)-14-ethyl-6,19-dimethoxy-16-(methoxymethyl)-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosan-4-ol
14-ethyl-4,6,19-trimethoxy-16-methyl-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosan-2-ol
14-benzyl-5,16-dihydroxy-5,7,12,13-tetramethyl-6h,7h,8h,10ah,13h,13ah,14h-oxacyclododeca[3,2-d]isoindol-2-one
C28H35NO4 (449.25659500000006)